We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.65B
Cap. Flow
% of AUM
97.21%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$91.9M |
| 2 |
CELG
Celgene Corp
CELG
|
+$79.7M |
| 3 |
Apple
AAPL
|
+$78.2M |
| 4 |
Qualcomm
QCOM
|
+$73.5M |
| 5 |
Amgen
AMGN
|
+$71.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.7% |
| 4 | Industrials | 8.01% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Comcast
CMCSA
$79.1B
| $11.8M | 0.25% |
+407,078
| New | +$11.2M |
|
127
Ecolab
ECL
$75.6B
| $11.7M | 0.24% |
+111,627
| New | +$12.2M |
|
128
Southwest Airlines
LUV
$22.1B
| $11.7M | 0.24% |
+275,440
| New | +$10.3M |
|
129
Agilent Technologies
A
$39.1B
| $11.5M | 0.24% |
+280,007
| New | +$11.3M |
|
130
Universal Health Services
UHS
$9.43B
| $11.2M | 0.23% |
+100,955
| New | +$10.6M |
|
131
Pitney Bowes
PBI
$2.42B
| $11.2M | 0.23% |
+458,521
| New | +$11.2M |
|
132
Karyopharm Therapeutics
KPTI
$168M
| $11.2M | 0.23% |
+19,867
| New | +$11.3M |
|
|
MDVN
133
DELISTED
MEDIVATION, INC.
MDVN
| $11.1M | 0.23% |
+223,000
| New | +$11.6M |
|
|
GG
134
DELISTED
Goldcorp Inc
GG
| $11M | 0.23% |
+595,796
| New | +$12.2M |
|
|
CHK
135
DELISTED
Chesapeake Energy Corporation
CHK
| $10.9M | 0.23% |
+2,796
| New | +$11.6M |
|
136
Ameren
AEE
$31.5B
| $10.8M | 0.23% |
+233,889
| New | +$9.94M |
|
|
WFM
137
DELISTED
Whole Foods Market Inc
WFM
| $10.8M | 0.23% |
+213,958
| New | +$9.43M |
|
|
HAR
138
DELISTED
Harman International Industries
HAR
| $10.8M | 0.22% |
+100,834
| New | +$10.4M |
|
139
UnitedHealth
UNH
$382B
| $10.1M | 0.21% |
+100,237
| New | +$9.5M |
|
|
B
140
Barrick Mining
B
$62.2B
| $10M | 0.21% |
+931,080
| New | +$11.5M |
|
141
State Street SPDR S&P Retail ETF
XRT
$365M
| $9.98M | 0.21% |
+208,000
| New | +$9.33M |
|
|
DNR
142
DELISTED
Denbury Resources, Inc.
DNR
| $9.9M | 0.21% |
+1,217,182
| New | +$12.6M |
|
143
Ralph Lauren
RL
$22.2B
| $9.87M | 0.21% |
+53,316
| New | +$9.2M |
|
144
Kohl's
KSS
$2.03B
| $9.72M | 0.2% |
+159,301
| New | +$9.21M |
|
145
Micron Technology
MU
$1.04T
| $9.62M | 0.2% |
+274,887
| New | +$9.1M |
|
|
HOT
146
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $9.56M | 0.2% |
+117,887
| New | +$9.2M |
|
147
International Paper
IP
$22.3B
| $9.49M | 0.2% |
+187,027
| New | +$9.16M |
|
148
TSMC
TSM
$2.09T
| $9.36M | 0.2% |
+418,000
| New | +$9.11M |
|
149
Molson Coors Class B
TAP
$7.68B
| $9.34M | 0.2% |
+125,297
| New | +$9.29M |
|
150
Exelon
EXC
$48.6B
| $9.29M | 0.19% |
+351,253
| New | +$9.01M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Candriam SCA, which disclosed 616 positions worth $4.78B. Its ten largest holdings account for 14% of the portfolio.
Its largest position is Gilead Sciences: 888,125 shares worth $83.7M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Financials and Technology.
- Candriam SCA's largest Q4 2014 buy was Gilead Sciences: 888,125 shares worth $83.7M.
- Candriam SCA's ten largest holdings make up 14% of its $4.78B portfolio in Q4 2014.
- Candriam SCA disclosed 616 positions in Q4 2014, its first 13F filing on record.
Based on Candriam SCA's 13F filing for Q4 2014, filed 26 Mar 2015.